Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells

  • 1,
  • 1,
  • 2,
  • 3,
  • 3,
  • 4,
  • 3,
  • 1Email author and
  • 4Email author
Contributed equally
BMC Cancer201616:374

https://doi.org/10.1186/s12885-016-2401-3

  • Received: 8 June 2016
  • Accepted: 8 June 2016
  • Published:

The original article was published in BMC Cancer 2014 14:373

Erratum

Unfortunately, the original version of this article [1] contained an error within Fig. 5. For testing Sema4D protein expression in PaTu8988 cells with/out SAHA treatment, the protein samples of Fig. 2D were re-tested by Western blot assay using Sema4D antibody (Fig. 5E). The correct version of Fig. 5E can be found below. This does not alter the conclusion of the result.
Fig. 5
Fig. 5

PaTu8988 cells were incubated with SAHA at indicated dosage for 48 hours, the protein expressions of Sema4D and tubulin were tested by Western blots. Experiments in this figure were repeated three times, and similar results were obtained. e SAHA suppresses PaTu8988 cell vasculogenic mimicry (VM)

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of General Surgery, the Third Hospital affiliated to Soochow University, Changzhou City, Jiangsu, 213003, China
(2)
Department of Neurology, the First Affiliated Hospital of Soochow University, Suzhou, China
(3)
Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, 215123, China
(4)
Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu, 215021, China

References

  1. Xu X, Yang L, Zheng L, Pan Y, Cao Z, Zhang Z, Zhou Q, et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. BMC Cancer. 2014;14:373. doi:10.1186/1471-2407-14-373.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

Advertisement